{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:57:08Z","timestamp":1761393428366,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.clinph.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T10:31:05Z","timestamp":1561199465000},"page":"1557-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Motor neuron disease with malignancy: Clinical and pathophysiological insights"],"prefix":"10.1016","volume":"130","author":[{"given":"Mana","family":"Higashihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvathi","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimeshan","family":"Geevasinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi A.J.","family":"Van den Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2019.05.026_b0005","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0010","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1212\/WNL.42.10.1951","article-title":"Magnetic brain stimulation: the silent period after the motor evoked potential","volume":"42","author":"Cantello","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2019.05.026_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinph.2019.05.026_b0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00314238","article-title":"Motor neuron disease and malignancies: results of a population-based study","volume":"235","author":"Chio","year":"1988","journal-title":"J Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2019.05.026_b0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N","article-title":"Nerve conduction studies in amyotrophic lateral sclerosis","volume":"23","author":"de Carvalho","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.05.026_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jnnp.11.2.73","article-title":"Primary sensory neuropathy with muscular changes associated with carcinoma","volume":"11","author":"Denny-Brown","year":"1948","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2019.05.026_b0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jnnp.2009.175463","article-title":"Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies","volume":"81","author":"Fois","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2019.05.026_b0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410410608","article-title":"Motor neuron syndromes in cancer patients","volume":"41","author":"Forsyth","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000087447","article-title":"Kuncl RW. Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors","volume":"25","author":"Freedman","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clinph.2019.05.026_b0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jamaneurol.2015.1872","article-title":"Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis","volume":"72","author":"Geevasinga","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/01.wnl.0000200962.94777.71","article-title":"The natural history of primary lateral sclerosis","volume":"66","author":"Gordon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2019.05.026_b0065","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","article-title":"Lymphoproliferative disorders and motor neuron disease: an update","volume":"48","author":"Gordon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2019.05.026_b0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ene.13295","article-title":"Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis","volume":"24","author":"Menon","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1474-4422(15)00014-9","article-title":"The sensitivity and specificity of threshold-tracking transcranial magnetic stimulation for the diagnosis of amyotrophic lateral sclerosis: a prospective study","volume":"14","author":"Menon","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087124","article-title":"Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis","volume":"9","author":"Menon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinph.2019.05.026_b0085","series-title":"Aid to the examination of the peripheral nervous system","first-page":"1","author":"O'Brien","year":"2004"},{"key":"10.1016\/j.clinph.2019.05.026_b0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jnnp.2006.097774","article-title":"Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease","volume":"78","author":"Stich","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2019.05.026_b0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.clinph.2019.05.026_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410400118","article-title":"Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma","volume":"40","author":"Verma","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","article-title":"Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy","volume":"1","author":"Voltz","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2019.05.026_b0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.20481","article-title":"Assessment of cortical excitability using threshold tracking techniques","volume":"33","author":"Vucic","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.05.026_b0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jnnp.2006.105056","article-title":"Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis","volume":"78","author":"Vucic","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2019.05.026_b0120","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/brain\/awl172","article-title":"Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease","volume":"129","author":"Vucic","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2019.05.026_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/jnnp.2009.183079","article-title":"Upregulation of persistent sodium conductances in familial ALS","volume":"81","author":"Vucic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2019.05.026_b0130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","volume":"131","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2019.05.026_b0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/jnnp-2012-304019","article-title":"Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights","volume":"84","author":"Vucic","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719309010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719309010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:54:04Z","timestamp":1761393244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245719309010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1388245719309010"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2019.05.026","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motor neuron disease with malignancy: Clinical and pathophysiological insights","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}